Plant Based CBD Therapeutics Products
Organically grown, plant-based therapeutics to replace chemicals. We grow our products on organic-equivalent farms, as supplements for inflammation, probiotics, sleep aid, and more, as opposed to chemicals mixed in a lab. Our products are based on International research done on CBD, probiotics, and a variety of other supplements. Our products are grown on the farm, not chemically derived. Our product development is based on science.
- Security Type
- Common Stock
- Min Investment
- Offering Date
- July 15, 2021
- Expected Close Date
- July 22, 2022
- Security Price
Margaret has spent most of her career in Biotechnology, in the area of clinical research and financials. She has worked for several notable biotechnology companies in Silicon Valley including Heartport, an innovator of heart therapies. She spent time at Aviron, supporting the development of the innovative Flumist product (nasal flu inoculation), and Genitope, which created personal gene therapies. More recently, Margaret has spent the last 10 years co-managing the family farm/vineyard and growing the wine business in Sonoma County. This includes creating wines, and other products from the farms' organic gardens. At Simply Sonoma, Margaret is focused on the orchestration, identification, and development of the company product portfolio, and markets nationally.
Angela Miller, VP of Operations
Angela Miller is the Vice President of Operations at Simply Sonoma. Angela has extensive experience in cross line-of-business, global project management, and analysis from inception to post-go-live. Angela spent more than 20 years working in IT, between Oracle Corp and Sun Microsystems, Inc., where she obtained expertise in global products, team building, troubleshooting, and customer relations/satisfaction. Prior career highlights include 7 years with Schwinn Cycling & Fitness, doing everything in the Fitness Division from project management to marketing and public relations. She also has numerous years of experience in people management, training, and coaching, where she developed a proven track record of leadership. Ms. Miller has responsibility for Simply Sonoma product operations and logistics, as well as investor relations and communications.
Paul Caracciolo, Chief Science Officer
After completing a degree in Earth Sciences, and Masters's course work at the University of Colorado in Biochemistry, Paul started his career in Biotechnology, developing human biopharmaceuticals for a company that was acquired by Amgen. Paul's efforts supported the development of multiple commercial Biotech products with sales of billions of dollars (including autoimmune products for arthritis and inflammation). Paul held the position of Chief Technology Officer for Aviron, the company that invented Flumist (the nasal flu inoculation). Paul has spent his entire career in healthcare and has held Chief Technology Officer positions at numerous hospital and clinic systems, such as Dignity Health 42 hospitals, Duke University Health System, and Stanford hospitals and clinics.
No reports have been submittedBecome a Reporter